Dr. Ravi Kiron, Managing Director at Adjuvant Ventures, presented today at The Bio2DeviceGroup (www.bio2devicegroup.org) on how to access opportunities in the midst of the paradigm shift happening on account of increasing globalization and the ever widening role played by the emerging markets. Kiron traced his own career history and shared about other similar paradigm shifts that helped him move on to his “next” opportunities. The days of blockbuster drugs are gone, said Kiron. The paradigm has shifted towards “personalized medicine” and open source access to medical data, and emerging markets are becoming key players, added Kiron. The talk was followed by interactive discussion and Q&A.